Public trial registry of the CCC-Munich

Trial AFFECT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AFFECT
World
Full title
:

Gemcitabine and nab-Paclitaxel Combined with the Oral Irreversible ErbB Family Blocker Afatinib in Patients with Metastatic Pancreatic Cancer: a Phase I b Trial

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C25.9 Pankreas, nicht näher bezeichnet
Trial design
World
Phase
:
I/II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Michael Quante 2. Med 2. Med Ismaninger Str. 22 81675 München Germany Magnifier